CM
KANG

Castleark Management’s iKang Healthcare Group, Inc. KANG Stock Holding History

Castleark Management’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,810
Closed -$180K – 436
2015
Q4 		$180K Buy
+8,810
New +$152K 0.01% 352

Other funds holding KANG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
ASI
All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Castleark Management's KANG Position: Q1 2016 in Review

Castleark Management sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2016, closing a stake of 8,810 shares — an estimated $180K sold.

Castleark Management first reported a position in KANG in Q4 2015 and held it in 1 quarter. The position peaked at $180K in Q4 2015. 73 funds tracked by Wall St. Rank hold KANG as of Q1 2016.

  • Castleark Management reported no remaining iKang Healthcare Group, Inc. position as of Q1 2016 after selling out during the quarter.
  • Castleark Management sold 8,810 iKang Healthcare Group, Inc. shares in Q1 2016, an estimated $180K.
  • Castleark Management first reported a position in iKang Healthcare Group, Inc. in Q4 2015 and held it in 1 quarter.
  • Castleark Management's iKang Healthcare Group, Inc. position peaked at $180K in Q4 2015.
  • 73 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2016.

Based on Castleark Management's 13F filing for Q1 2016, filed 17 May 2016.